Oral pills are often more expensive monthly and may require longer use to achieve similar results
27 The plan had previously covered these drugs for weight loss, but noted that the cost was expected to grow to more than $1 billion by 2030, and roughly double the amount that enrolled members would have to pay in monthly premiums for their coverage
However, Novo Nordisk's chief scientific officer has suggested that they are investigating a long-acting GLP-1 drug candidate that would require administration once a year rather than once a week
Compounded semaglutide is a customized medication created by specialized pharmacies to meet individual patient needs
Microdosing, on the other hand, is used more like a precision tool, subtle appetite control, smoother insulin response, and support for cosmetic or athletic goals
Additionally, the phase 2 MOMENTUM clinical trial of pemvidutide (a dual GLP-1/GCG agonist) showed that only 21.9% of WL was attributable to reductions in lean mass at 48 weeks (overall WL 10.315.6% across doses) [64]